Dr David Etoori

Research Fellow

United Kingdom

Email
David

I am a researcher in the NIHR Health Protection Research Unit (HPRU) in Immunisation and Vaccination and the Electronic Health Records (EHR) group. My work uses EHR data to better understand vaccination uptake and coverage in England.

Before joining LSHTM, I worked at UCL. First with the ECHILD project which used linked education and health data to investigate the links between health and educational attainment, and then with the HPRU in blood-borne viruses and STIs where my work aimed to understand the epidemiology of hepatitis C in England in order to improve the care and management of those affected.

I earned my PhD from LSHTM in 2020.

Prior to that, I worked as an Epidemiologist with Medecins Sans Frontieres in Niger and Eswatini.

In my free time, I can be found running long distances, getting lost in fantasy and sci-fi novels, crafting historical fiction, and at the occasional salsa class.

Affiliations

Department of Infectious Disease Epidemiology and International Health

Faculty of Epidemiology and Population Health

Research

My research encompasses immunisation, infectious diseases, and health data science. I aim to make better use of available electronic health record data to improve surveillance of infectious diseases, and to understand uptake, coverage and factors that influence vaccination, in order to improve the health of the public.

Research Area

Maternal health

Child health

Data science

Electronic health records

Epidemiology

Immunisation

Vaccinations

Disease and Health Conditions

HIV/AIDS

COVID-19

Hepatitis

Sexually transmitted infections

Influenza

Selected Publications

Qualitative evaluation of the barriers and facilitators to a retrospective hepatitis C virus patient re-engagement exercise in England .

Stuart, A; Hörst, C; ETOORI, D; Lorencatto, F; Rosenberg, W; Lowndes, C; Simmons, R; Mandal, S; Gillyon-Powell, M; Desai, M;

2025

BMJ open

Corrigendum to “Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response” [J Hepatol (2025) 101382]

Fink, DL; ETOORI, D; Hill, R; Idilli, O; Kartikapallil, N; Payne, O; Griffith, S; Bradford, HF; Mauri, C; Kennedy, PT F; McCoy, LE; Maini, MK; Gill, US;

2025

JHEP Reports

Trends in the effect of direct acting antivirals on mortality in people diagnosed with hepatitis C in England using routine surveillance data

ETOORI, D; Simmons, R; Desai, M; Powell, A; Trembling, P; Rosenberg, W;

2025

European Association for the Study of the Liver (EASL)

Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response

Fink, DL; ETOORI, D; Hill, R; Idilli, O; Kartikapallil, N; Payne, O; Griffith, S; Bradford, HF; Mauri, C; Kennedy, PT F; McCoy, LE; Maini, MK; Gill, US;

2025

JHEP Reports

EXSPECT: ELF Cross-comparison between serum and plasma collection tubes.

Hung, A; ETOORI, D; Modi, R; Gee, M; Rosenberg, W;

2025

Clinica chimica acta; international journal of clinical chemistry

Trends in mortality for individuals diagnosed with HCV following the roll-out of directly acting antivirals in England

ETOORI, D; Simmons, R; Desai, M; Powell, A; Trembling, P; Sabin, C; Rosenberg, W;

2025

The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a Clinical Database Case-Finding Tool for Hepatitis B, Hepatitis C and HIV in Primary Care.

ETOORI, D; Cococcia, S; Srivastava, A; Flanagan, S; Nixon, G; Bobba, S; Warner, A; Sennett, K; Sabin, C; Morgan, S; Rosenberg, WM;

2024